Cemiplimab and ISA101b Vaccine in Adult Participants With Recurrent/Metastatic Human Papillomavirus (HPV)16 Cervical Cancer Who Have Experienced Disease Progression After First Line Chemotherapy
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Jiangsu HengRui Medicine Co., Ltd.
Esperas Pharma Inc.
Aprea Therapeutics
Aprea Therapeutics
Akeso
Stanford University
Mundipharma Research Limited
Chinese PLA General Hospital
Seoul National University Hospital
Memorial Sloan Kettering Cancer Center
Nykode Therapeutics ASA
ARCAGY/ GINECO GROUP
pharmaand GmbH
pharmaand GmbH
pharmaand GmbH
H. Lee Moffitt Cancer Center and Research Institute
Ruhr University of Bochum
Ruhr University of Bochum
Kiadis Pharma
Southern Illinois University
AGO Study Group
Northwestern University
Peking Union Medical College Hospital
Chipscreen Biosciences, Ltd.
Masonic Cancer Center, University of Minnesota
University of Virginia
Dana-Farber Cancer Institute
Eli Lilly and Company
Novartis
Incyte Corporation
Vejle Hospital
ARCAGY/ GINECO GROUP
Jonsson Comprehensive Cancer Center
Chipscreen Biosciences, Ltd.
National Institutes of Health Clinical Center (CC)
Celgene
Assistance Publique - Hôpitaux de Paris
NYU Langone Health
Mayo Clinic
University College, London
Daiichi Sankyo
University College, London
Massachusetts General Hospital
H. Lee Moffitt Cancer Center and Research Institute
Fred Hutchinson Cancer Center
University of Louisville
Fred Hutchinson Cancer Center
AstraZeneca
Novartis